Clinical Development, Clinical Research and Download

Getting the Pulse on Biopharma and Biotech Companies: Differing Perspectives on Clinical Development

PPD

NOVEMBER 21, 2023

To keep a pulse on this rapidly changing industry, the PPD clinical research business of Thermo Fisher Scientific surveyed 150 leaders in the biopharma and biotech industries for the second consecutive year. Differences in size, resources and agility have led the two groups to take different approaches to clinical development.

Clinical Development

Clinical Development Clinical Trials Trials Clinical Research

FSP Engagements Continue to Gain Popularity, Drive Success

PPD

MARCH 26, 2024

The PPD clinical research business of Thermo Fisher Scientific conducts an annual survey of more than 150 leaders at pharmaceutical companies around the globe to assess trends in drug discovery and development, including preferences around outsourcing and functional service provider (FSP) utilization.

Clinical Research

Clinical Research Pharmaceutical Companies Clinical Development Drug Development

Reimagining CRO Partnerships: The Emerging Preference for Midsize Organizations

Conversations in Drug Development Trends

APRIL 15, 2024

As the clinical research landscape continually evolves, the choice of a Contract Research Organization (CRO) partner can significantly impact the success of drug development programs. Discover how Worldwide is positioned to meet your needs with agility, expertise, and a truly personalized approach.

Clinical Trials

Clinical Trials Clinical Development Clinical Research Pharmaceutical Companies

Evolution of Clinical Operations Drives FSP Staffing Models to the Forefront

PPD

OCTOBER 2, 2024

Efficient and effective clinical operations are the backbone of successful clinical trials, and today’s biopharmaceutical, biotech and medical device organizations have a range of options to meet their needs in this critical area.

Clinical Trials

Clinical Trials Clinical Development Clinical Research Trials

Seven Strategies to Avoid Common Pitfalls in Vaccine Development

PPD

JUNE 13, 2023

To rise above the competition, sponsors must understand the common pitfalls of vaccine development and have strategies in place to avoid them. It is imperative that the right vaccine development partner demonstrates expertise from early clinical development to study design, execution, regulatory submission and commercialization.

Vaccine

Vaccine Clinical Trials Clinical Research Trials

CROMSOURCE Consolidates Strategic Site Support Service

The Pharma Data

JANUARY 27, 2021

“Our commitment to supporting clinical research sites with strategic flexible resources has been increasingly important over the past 12 months in particular. View original content to download multimedia: [link]. VERONA, Italy , Jan. ” About CROMSOURCE. For more information, visit www.cromsource.com. Source link.

Clinical Research

Clinical Research Clinical Trials International Clinical Development

The Power of Bespoke Hybrid FSP/FSO Solutions

PPD

JUNE 17, 2024

Our PPD FSP solutions help biotech and biopharmaceutical companies meet their timelines by providing top-tier functional expertise that complements existing capabilities and helps companies tackle their unique clinical development challenges.

Clinical Trials

Clinical Trials Clinical Development Trials International

Navigating the Global Clinical Landscape: CTA or IND for Your First-in-Human Study?

Conversations in Drug Development Trends

MARCH 7, 2024

Are there differential financial incentives to encourage sponsors to initiate early phase clinical research under a CTA, and how do those incentives compare to incentives that exist to initiate the same research under an IND? For additional insights, download our full white paper, “ First-in-Human Studies: IND or CTA? ”.

Clinical Trials

Clinical Trials Trials FDA Drug Development

Five Predictions for the Biopharma and Biotech Industries in 2024

PPD

NOVEMBER 30, 2023

To get a pulse on the changing industry, the PPD clinical research business of Thermo Fisher Scientific surveyed 150 biotech and biopharma leaders for the second year in a row to illuminate industry trends, challenges and sentiments. Download the full 2023 report to access all the insights.

Clinical Trials

Clinical Trials Trials Clinical Research Drug Development

UNION therapeutics A/S receives FDA approval for IND of oral next generation PDE4-inhibitor (orismilast) for investigation in plaque psoriasis

The Pharma Data

JANUARY 6, 2021

“Further, PDE4-inhibition is a well-documented pharmacological target for a number of other inflammatory indications, and we look forward to advancing our clinical research to realize the full potential of orismilast for the benefit of the millions of patients living with inflammatory conditions globally,” adds Professor Sommer.

FDA Approval

FDA Approval FDA Clinical Development Clinical Research

Keeping tabs on Covid-19: Starpharma creates slow release remdesivir nanoparticl…

The Pharma Data

SEPTEMBER 11, 2020

“The ability to deliver remdesivir via a long-acting, subcutaneous injection has the potential to expand its application in countries with less developed healthcare systems and help improve patient convenience,” Fairley added. Covid-19 command center aims to accelerate clinical research by individual sponsors to combat disease.

Clinical Trials

Clinical Trials Pharma Companies Trials Hospitals

Diamyd Medical and Critical Path Institute announce data sharing collaboration to develop advanced drug development tools in type 1 diabetes

The Pharma Data

DECEMBER 15, 2020

It is funded by the world’s leading charities dedicated to diabetes research, JDRF, and Diabetes UK, guided by both organizations’ strong commitment to facilitate deep interrogation of consolidated community-wide trial data as a means to accelerate clinical research and therapeutic development for T1D.

Drug Development

Drug Development Clinical Trials Trials Vaccine

Article FDA Thank You FDA updates set the stage for broader use of harmonized standards for safety reporting

Agency IQ

APRIL 8, 2024

Since these issues could occur during the investigational phase of clinical development as well as in the post-marketing setting—and product status could very well differ by country/region—ICH members determined that these guidelines should be developed to facilitate the exchange of information in both settings.

FDA

FDA Production Regulations Vaccine

Drug Discovery Digest

Getting the Pulse on Biopharma and Biotech Companies: Differing Perspectives on Clinical Development

FSP Engagements Continue to Gain Popularity, Drive Success

Reimagining CRO Partnerships: The Emerging Preference for Midsize Organizations

Evolution of Clinical Operations Drives FSP Staffing Models to the Forefront

Seven Strategies to Avoid Common Pitfalls in Vaccine Development

CROMSOURCE Consolidates Strategic Site Support Service

The Power of Bespoke Hybrid FSP/FSO Solutions

Navigating the Global Clinical Landscape: CTA or IND for Your First-in-Human Study?

Five Predictions for the Biopharma and Biotech Industries in 2024

UNION therapeutics A/S receives FDA approval for IND of oral next generation PDE4-inhibitor (orismilast) for investigation in plaque psoriasis

Keeping tabs on Covid-19: Starpharma creates slow release remdesivir nanoparticl…

Diamyd Medical and Critical Path Institute announce data sharing collaboration to develop advanced drug development tools in type 1 diabetes

Article FDA Thank You FDA updates set the stage for broader use of harmonized standards for safety reporting

Stay Connected